Cookies on this site

The DeLIVER early detection of hepatocellular carcinoma research team will evaluate non-contrast-enhanced MRI and compare it to standard of care ultrasound in a cohort of patients under surveillance for liver cancer.

MRI machine from the inside © Pixabay

Researchers from the Universities of Oxford, Nottingham, Bournemouth and Glasgow Caledonian will lead the £2.2 million AMULET clinical study into the use of a new imaging technique for surveillance of liver cancer in patients with cirrhosis. Led by Dr Michael Pavlides (study chief investigator, Radcliffe Department of Medicine, University of Oxford),  Professor Susan Francis (study lead technical investigator, University of Nottingham) and Associate Professor Jamie Franklin (study lead radiologist, Bournemouth University), the study is funded by the Efficacy and Mechanism Evaluation (EME) Programme, a partnership between the National Institute for Health and Care Research and the Medical Research Council. The team will compare non-contrast-enhanced magnetic resonance imaging (MRI) to the standard of care ultrasound to assess which imaging technique is better for diagnosing liver cancer earlier.

Liver cancer incidence is increasing and by 2038-2040 there could be around 9,700 new diagnoses of liver cancer every year (Cancer Research UK). Most cases of liver cancer arise in people with liver cirrhosis. Therefore, people with cirrhosis undergo regular surveillance by ultrasound with the aim of detecting liver cancer earlier. The earlier that liver cancer is detected, the more likely that treatment will be successful. However, liver ultrasound has poor sensitivity in some patients meaning that early liver cancers can be missed.

 

Read the full story on the Oxford Centre for Early Cancer Detection (OxCODE) website.

Similar stories

Research shows for the first time that standard non-contrast CT scans can be analysed by AI to reveal hidden coronary inflammation

Researchers from 27 institutions across UK, USA, Europe and Australia, led by a team at the University of Oxford, have demonstrated how an AI technology can measure inflammation in the heart’s arteries using low-radiation CT heart scans typically used to measure calcium score.

Five European Research Council (ERC) Synergy Grants awarded to Oxford researchers for ambitious new collaborations

Five Oxford University academics are to co-lead ambitious new research projects backed by European Research Council (ERC) Synergy Grants, part of the EU’s Horizon Europe research and innovation programme. Synergy Grants support groups of two to four outstanding researchers who combine complementary expertise and resources to tackle ambitious scientific challenges that could not be addressed by individual teams alone.

Professor Ole Jensen (Department of Experimental Psychology) and colleagues received €13.6 million to discover when the brain is ready for language and social understanding

The team will use new wearable brain sensors to track cognitive development from before birth to eight years of age.

New 'molecular glue' helps break down antibiotic resistance enzymes in E. coli

Oxford University scientists have discovered a new approach to tackle antimicrobial resistance (AMR), using 'molecular glues' to encourage bacteria to destroy their own resistance-causing enzymes. The study has been published in Angewandte Chemie International Edition.

Stronger immune system may help protect against prostate cancer

Higher levels of proteins involved in activating and coordinating the immune system were associated with a lower risk of developing prostate cancer, in a new study led by researchers at the Nuffield Department of Population Health.

The Nuffield Department of Women's & Reproductive Health has published its Biennial Report 2024–26

The Biennial Report 2024–26 highlights two years of research excellence, innovation, collaboration and growth.